Read the complete weekly issue
Reference Range WeeklyIssue 8
A bedside table with a partly opened weekly pill organizer, a glass of water and an hourglass midway through.

Stopping statins after 70: acceptable at two years, less so later

Plenty of people over 70 take a statin not because they have had a heart attack, but to prevent a first one. After years on the pill, a fair question comes up: is it still earning its place? STREAM is one of the first randomized trials to test stopping directly. It was presented and published on 7 November, two days before the week this issue covers, and we had not reported it before.

At 24 centers in Switzerland, France and the Netherlands, 1,880 people aged 70 and older (average age 77.5) were randomly assigned to stop all cholesterol-lowering medicine or carry on. None had known heart disease or a past stroke. All had at least two chronic conditions, and none had a specific reason to stop, such as side effects.

The main measure combined nonfatal heart attack, nonfatal ischemic stroke (the kind caused by a blocked blood vessel) and death from any cause. At two years, stopping passed the trial's test for not being meaningfully worse: event-free time worked out to 96.5 weeks after stopping versus 98.5 weeks with continuing. The lead investigator estimated one extra major heart event or death for every 40 people who stopped.

Further out, the gap widened. Over up to four years, heart attack, stroke or death happened to 12.7% of those who stopped and 9.2% of those who continued. Median follow-up was about two years, so that later difference rests on fewer people, and about 14% of participants switched away from their assigned approach. Stopping did not show a measurable payoff either: quality of life, pain, falls and muscle-loss risk did not differ significantly between the groups.

After the trial ended, its independent monitoring board recommended that people in the stopping group discuss restarting a statin with their doctors.

Get the next issue by email

Our weekly newsletter on what is new in health research, explained for curious readers and linked to the original studies. One email a week.

Sources

Source titles are preserved as published.

Reference Range Weekly is for general information. It does not provide medical advice, diagnosis, or treatment.